Dataset Open Access

Optimisation of HTT-HAP40 purification using heparin affinity chromatography (2019/01/14)

Harding, Rachel; Hutchinson, Ashley; Seitova, Alma; Arrowsmith, Cheryl; Edwards, Aled

BibTeX Export

  author       = {Harding, Rachel and
                  Hutchinson, Ashley and
                  Seitova, Alma and
                  Arrowsmith, Cheryl and
                  Edwards, Aled},
  title        = {{Optimisation of HTT-HAP40 purification using 
                   heparin affinity chromatography (2019/01/14)}},
  month        = jan,
  year         = 2019,
  note         = {{Dr. Harding is the recipient of the Huntington's 
                   Disease Society of America Berman Topper Career
                   Development Fellowship which funds and supports
                   this research. Dr. Harding's research is also
                   supported with generous funding from the
                   Huntington Society of Canada and the CHDI
                   Foundation. The SGC is a registered charity
                   (number 1097737) that receives funds from AbbVie,
                   Bayer Pharma AG, Boehringer Ingelheim, Canada
                   Foundation for Innovation, Eshelman Institute for
                   Innovation, Genome Canada through Ontario Genomics
                   Institute [OGI-055], Innovative Medicines
                   Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766],
                   Janssen, Merck KGaA, Darmstadt, Germany, MSD,
                   Novartis Pharma AG, Ontario Ministry of Research,
                   Innovation and Science (MRIS), Pfizer, São Paulo
                   Research Foundation-FAPESP, Takeda, and Wellcome.}},
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.2553669},
  url          = {}
All versions This version
Views 309309
Downloads 107107
Data volume 51.9 MB51.9 MB
Unique views 278278
Unique downloads 8282


Cite as